Tomiron

Tomir Therapeutics is a biotechnology company focused on developing regenerative therapies for dental health, specifically targeting the prevention and treatment of dental caries. The company's lead program utilizes small molecule or peptide-based modulators of the Wnt signaling pathway to stimulate the natural repair of tooth enamel and dentin. By leveraging insights into the molecular mechanisms of tooth development and repair, Tomir aims to provide a biological alternative to traditional fillings and restorative procedures. The company is currently in the pre-clinical stage, advancing its proprietary candidates toward human clinical trials.